Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.51)
# 3,447
Out of 4,966 analysts
53
Total ratings
57.58%
Success rate
-4.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $192.98 | -4.65% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $339.88 | +2.98% | 5 | Aug 8, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $132.66 | +7.04% | 6 | Jul 18, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $9.15 | +118.58% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $12.51 | +555.48% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $126.41 | +96.19% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $473.30 | -28.37% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.71 | +111.03% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.71 | +1,478.95% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $106.10 | +4.62% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $75.34 | +90.80% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $95.82 | -41.56% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $90.54 | -18.27% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $81.34 | -5.74% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.33 | +629.93% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $61.27 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $192.98
Upside: -4.65%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $339.88
Upside: +2.98%
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $132.66
Upside: +7.04%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $9.15
Upside: +118.58%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $12.51
Upside: +555.48%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $126.41
Upside: +96.19%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $473.30
Upside: -28.37%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.71
Upside: +111.03%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.71
Upside: +1,478.95%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $106.10
Upside: +4.62%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $75.34
Upside: +90.80%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $95.82
Upside: -41.56%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $90.54
Upside: -18.27%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $81.34
Upside: -5.74%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.33
Upside: +629.93%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $61.27
Upside: -